Compound ID | 554
Class: Fluoroquinolone
Spectrum of activity: | Gram-positive |
Details of activity: | Active against a number of species of Mycobacteria including M. tuberculosis, M. fortuitum and M. smegmatis |
Description: | Renau TE, Gage JW, Dever JA, et al. Antituberculosis activity and side effect profiles of 8 new quinolones optimised for antimycobacterial effects. 36th-Intersci-Conf-Antimicrobial-Agents-Chemother 1996; 136. |
Institute where first reported: | Parke Davis Pharmaceutical Research (Pfizer, USA) |
Year first mentioned: | 1996 |
Highest developmental phase: | Preclinical |
Development status: | Inactive |
Chemical structure(s): | |||||||||||
|
|
External links: | |
PubChem link: | https://pubchem.ncbi.nlm.nih.gov/compound/459968 |
Citation: | https://journals.asm.org/doi/10.1128/aac.40.10.2363 |